help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, X. K.
Right arrow Articles by Pfahl, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, X. K.
Right arrow Articles by Pfahl, M.

Molecular Endocrinology, Vol 5, 1909-1920, Copyright © 1991 by Endocrine Society


ARTICLES

DNA binding and dimerization determinants for thyroid hormone receptor alpha and its interaction with a nuclear protein

XK Zhang, PB Tran and M Pfahl
Cancer Center, La Jolla Cancer Research Foundation, California 92037.

The gel retardation assay was used to analyze the role of the thyroid hormone receptor alpha (TR alpha) ligand-binding domain (LBD) in controlling receptor interaction with a thyroid hormone responsive element (TRE). While wild type receptor TR alpha binds to the TRE mainly as monomer, deletion of 85 amino acids from its C-terminus results in a mutant receptor with enhanced DNA binding that forms several slow mobility complexes as revealed by gel retardation assay. Receptor deletion mutants that lack most of the LBD show significantly elevated DNA binding and are still able to bind to DNA as two complexes. Thus, the C-terminal end of TR alpha appears to interfere with the dimerization/oligomerization function and DNA binding of TR alpha. All C-terminal deletion mutants have lost their T3-responsive activator function, but some show constitutive activity. Nuclear factor from several cell lines, including CV-1, F9, and GC cells, interacts with TR alpha receptor to form a larger molecular weight complex as determined by gel retardation assay. This factor could not be detected in HeLatk- cells, where TR alpha does not activate a TRE-containing reporter gene. The nuclear factor is heat sensitive and does not bind to TRE itself but can interact with TR alpha in the absence of DNA. Deletion analysis demonstrates that the leucine zipper-like sequence located in the LBD of TR alpha is involved in this interaction. Together, our data suggest that TR alpha contains a dimerization function outside the LBD which is inhibited by the carboxy-terminal region, while the leucine zipper-like sequence in the LBD is required for interaction with a nuclear factor.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
V. A. B. Drover, N. C. W. Wong, and L. B. Agellon
A Distinct Thyroid Hormone Response Element Mediates Repression of the Human Cholesterol 7{alpha}-Hydroxylase (CYP7A1) Gene Promoter
Mol. Endocrinol., January 1, 2002; 16(1): 14 - 23.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K.-h. Lin, H.-y. Shieh, and H.-C. Hsu
Negative Regulation of the Antimetastatic Gene Nm23-H1 by Thyroid Hormone Receptors
Endocrinology, July 1, 2000; 141(7): 2540 - 2547.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Sato, M. D. Sadar, N. Bruchovsky, F. Saatcioglu, P. S. Rennie, S. Sato, P. H. Lange, and M. E. Gleave
Androgenic Induction of Prostate-specific Antigen Gene Is Repressed by Protein-Protein Interaction between the Androgen Receptor and AP-1/c-Jun in the Human Prostate Cancer Cell Line LNCaP
J. Biol. Chem., July 11, 1997; 272(28): 17485 - 17494.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Reginato, J. Zhang, and M. A. Lazar
DNA-independent and DNA-dependent Mechanisms Regulate the Differential Heterodimerization of the Isoforms of the Thyroid Hormone Receptor with Retinoid X Receptor
J. Biol. Chem., November 8, 1996; 271(45): 28199 - 28205.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. J. Piedrafita, R. B. Molander, G. Vansant, E. A. Orlova, M. Pfahl, and W. F. Reynolds
An Alu Element in the Myeloperoxidase Promoter Contains a Composite SP1-Thyroid Hormone-Retinoic Acid Response Element
J. Biol. Chem., June 14, 1996; 271(24): 14412 - 14420.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Langley, Z.-x. Zhou, and E. M. Wilson
Evidence for an Anti-parallel Orientation of the Ligand-activated Human Androgen Receptor Dimer
J. Biol. Chem., December 15, 1995; 270(50): 29983 - 29990.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Bendik and M. Pfahl
Similar Ligand-induced Conformational Changes of Thyroid Hormone Receptors Regulate Homo- and Heterodimeric Functions
J. Biol. Chem., February 17, 1995; 270(7): 3107 - 3114.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. Lehmann, L Jong, A Fanjul, J. Cameron, X. Lu, P Haefner, M. Dawson, and M Pfahl
Retinoids selective for retinoid X receptor response pathways
Science, December 18, 1992; 258(5090): 1944 - 1946.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society